Do Treatments Differ Depending on the Stage of Alzheimer's Disease?

Read Transcript

The FTA has not approved any therapies yet for the very early stages of Alzheimer's Disease, that we call Mild cognitive impairment. Once the disease is caused functional impairment, we treat with drugs that boost the cedocholine. We also now have FTA approval to treat the later stages with drugs that boost cedocholine we call them cholinesterase inhibitors and also drugs that block the gludomade receptor.